イスラエルで最高の肝癌医師 - トップ20名の医師

ペレス・シャロン医師は、ソウラスキー医療センターにて化学療法や分子標的療法を含む肝臓がんの高度治療を専門としています。腫瘍学研究にも積極的に貢献し、根拠に基づいた患者ケアの実践に努めています。

• 肝臓がんに対する肝切除術および化学塞栓療法を実施
• 分子標的療法および免疫療法アプローチの専門家
• 臨床試験に対する患者の意識に関する研究を実施

メリムスキー教授はスーラスキー医療センターの肉腫ユニットを率い、41年の経験の経験を持つ肝臓癌治療の深い専門知識を有しています。

• 軟部組織および骨腫瘍学の専門医
• 肉腫に関するESMOファカルティのメンバー
• テルアビブ大学腫瘍学科元主任
• 腫瘍免疫学における広範な研究実績

この医師は、消化管腫瘍の治療において30年以上の経験を持つ、著名な消化器専門医です。GIがんの予防、早期診断、および治療を専門としており、Sourasky Medical CenterのCancer Prevention Centerを率いています。

ヘブライ大学で一般医学の学位を取得し、テルアビブ大学で消化器学の専門を修了したこの医師は、NewYork-Presbyterian Centerで研究を行いました。この医師は300以上の論文を発表しており、American Association for Cancer ResearchやEuropean Society of Digestive Oncologyを含む、いくつかの著名な組織のメンバーです。

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

テルアビブの主要医療機関であるスーラスキー医療センターの腫瘍科部長を務めるウォルフ教授は、最高水準のチームを率いています。

• シェバ医療センターにて腫瘍内科学および内科学を専門的に修得
• UCLAシダーズ・サイナイ医療センターにてポストドクトラルフェローシップを修了
• ASCOおよびAACRをはじめとする主要腫瘍学会の会員
• テルアビブ大学サックラー医学部にて上級講師を務める

Dr. Ron Greenberg is an abdominal surgeon; a top specialist in open and minimally invasive and Whipple surgery as well. Has over 20 years of experience. Heads the Colorectal Surgery Department at Sourasky Medical Center.

Dr. Menahem Ben-haim is one of the top surgeons with overall experience for more than 28 years. He is among the best specialists to treat liver, pancreatic and other gastrointestinal cancers. The doctor manages Whipple surgery and other interventions to manage oncological conditions.

この医師は結腸直腸、膵臓、および消化器外科を専門としており、特にウィップル手術において専門知識を持っています。45年以上の実績を持ち、この医師はイスラエルで最も著名なウィップル手術の外科医の一人として認識されています。

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

アレクサンダー・ベニー博士は、ランバム医療センターの腫瘍学者であり、英語とヘブライ語を話し、この分野で豊富な経験と教育を受けています。

• 専門分野：腫瘍学
• 言語：英語、ヘブライ語
• 教育：医学博士、フィレンツェ医科大学校、イタリア；イスラエル国家試験、医学および放射線腫瘍学；イスラエル認定腫瘍学者；腫瘍学における基礎科学 - コース；現代の小線源治療技術に関するESTRO教授コース；欧州共同体の医学における委員会試験
• 専門職経験：回転インターンシップ - ランバム医療センター、ハイファ、イスラエル；レジデンシー、腫瘍学部（医学および放射線）、ランバム医療センター、ハイファ、イスラエル；基礎科学、免疫学部門、カルメル病院、ハイファ、イスラエル；上級医師、腫瘍学部。ランバム医療センター、ハイファ、イスラエル；オンコロジーサービス責任者、イタリア総合病院、ハイファ、イスラエル；オンコ婦人科クリニック、ランバム医療センター、ハイファ、イスラエル；消化器腫瘍学クリニック、ランバム医療センター、ハイファ、イスラエル；放射線療法部門の責任者、ランバム医療センター、ハイファ、イスラエル；消化器系悪性腫瘍サービスのディレクター
• 連絡先 病院

教育と上級トレーニング コース

• 1989年 - ヘブライ大学で高等医学教育を受ける;
• 1995年 - ハダッサ大学病院で内科および消化器科の研修を修了する。
• 2001年 - 2002年 - ニューヨークのシナイ医学部肝疾患部門でスコット・フリードマン教授とのインターンシップを行う。

現在、リファート・サファディ教授は肝疾患治療の分野で優れた専門家であり、体細胞移植センターの開発委員会のメンバーで、ハダッサ医療センター肝疾患ユニットの責任者です。教授は複数の国際肝研究協会のメンバーであり、専門分野で多くの論文を執筆しています。サファディ教授は、科学医学ジャーナル「Clinical Science」の編集委員会メンバーです。

リファート・サファディ氏は、多くの科学賞の受賞者です。特に彼は、mRNAを用いた肝線維化の免疫調節過程の研究でハダッサ賞を繰り返し受賞しています。同じ分野での業績により、教授はシャロン・ドンスキー賞およびイスラエル消化器病学と肝臓学協会の賞も受賞しました。

Tamar Jablonski-Perec is an oncologist at the Hadassah Medical Center who received her Doctor of Medical Sciences at the Hebrew University in Jerusalem and completed an internship at the renowned Sloan-Kettering Cancer Center in New York. Her key takeaways include:

• Head of Institute of Oncology in 1994
• Head of Breast Cancer Treatment Center in 1998
• Professor of the Department of Oncology at the Hebrew University in 2006
• Member of several international cancer communities
• Awarded a scholarship from the Hadassah Medical School

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Radiotherapist

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.